Mannitol and 3% hypertonic saline (HTS) are the most used agents in paediatric patients; however, there hasn’t been enough evidence to favour one agent over the other. Objectives Compare both the ...
Objectives To determine the impact of inhaled mannitol on exacerbation rates in patients with non-cystic fibrosis (CF) bronchiectasis. Secondary endpoints included time to first exacerbation, duration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results